PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

FDA Struggles to Advance Biosimilars

The Patient-Engagement Quest: A Conversation with DIA’s Barbara Lopez Kunz

Pharm Exec's 14th Annual Press Audit: Opioid Crisis Takes Center Stage

Advertisement
Top Story
New Trends in Biopharma M&A
M&A-driven dealmaking in 2018 across the biopharmaceutical industry is on track to becoming the second highest of the decade. Michelle Maskaly reports
/Read more/
Advertisement
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
Biotech Focus
Critical Issues for Smaller Biotechs and Emerging Biopharmas
Daniel Patrick discusses the small biotech company journey from an incubator of ideas to the ability to shepherd an R&D asset through its pipeline to achieving commercial success
/Read more/
Advertisement
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Read more
Biotech Focus
The Secret to Attracting and Retaining Biotech Talent
The success of a biotech company is largely dependent upon a leader's ability to attract and hire experienced employees who are passionate about the cause, writes Eloxx Pharmaceuticals CEO Robert E. Ward
/Read more/
Advertisement
Leverage Your Data to Meet Rising Expectations within Life Sciences
Thursday, September 13, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now
Calendar
/ August 20–22: Transparency and Aggregate Spend 2018 /
Washington, DA, PA
/ September 25–26: Finance and Accounting for Bioscience Companies /
Boston, MA
/ September 25–26: 4th Annual Bio/Pharmaceutical Product Launch Summit /
Cambridge, MA
/ September 27: 3rd Edition Drug Pricing Transparency Congress /
Philadelphia, PA
/ October 2–3: Advanced Therapies Commercialization Congress /
Amsterdam, The Netherlands
/ November 14–15: Commercial Data Insights 2018 /
Philadelphia, PA
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences /
London, UK
/ November 28–29: Compliant Patient Support Programs Summit /
Chicago, IL
/ December 3–4: Digital Therapeutics /
New York, NY
/ December 4–5: Bio/Pharma Compliance Congress on Non-Promotional Activities /
Philadelphia, PA
/ December 4–5: Managed Markets Compliance Congress 2018 /
Philadelphia, PA
/ December 12: Specialty Product Data Strategies /
Philadelphia, PA
Advertisement
Biotech Focus
Face It — You're Not a Biotech Anymore
With increasing responsibilities and decision-making post-discovery, the traditional label of "biotech" is changing, writes Lisa Henderson
/Read More/
Audio
Pharm Exec Podcast: Emerging Biotech in NYC
Nancy Thornberry, CEO of Kallyope, talks with Pharm Exec's Michelle Maskaly and Christen Harm about New York City as an emerging hotspot for biotech incubators, and the challenges and opportunities related to space, location, recruitment, and funding
/Click here to listen/
Industry update
// Biopharma company VIVUS (Campbell, CA) announced the appointment of Ken Suh to the position of President. // Bellicum Pharmaceuticals (Houston, TX) appointed Thierry Darcis, M.D., M.B.A. as General Manager of Europe. // Concept Life Sciences (Manchester, UK), appointed Sarah Harris as Business Development Director for the East Coast, USA. // Prescient Healthcare Group appointed Dr. Paul Harney as President, North America. He has also been named to Prescient's Board of Directors. // ObsEva SA (Geneva, Switzerland and Boston, MA) announced the appointment of a Chief Commercial Officer, Wim Souverijns, who will be based at the company headquarters in Geneva. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com